CelaCare Technologies, Inc.
Specialty pharmaceutical and biotechnology company engaged in development of novel antimicrobial topical and oral formulations
CelaCare Technologies, Inc. is an early-stage Harding University spin-out specialty pharmaceutical and biotechnology company. The company is engaged in the development of a portfolio of novel products primarily focused on mucosal and topical therapy markets valued at greater than $25B in the U.S. Broad patent protection protects the company's Innovative technology. Importantly, the company is led by experienced management and advisors.